Skip to main content

Jixuan (Jessie) completed her PhD in 2018 at UNSW. She joined CMRI in 2021, where she is investigating the potential of modulating the Alternative Lengthening of Telomeres (ALT) pathway as a form of cancer therapy. 

She is currently studying therapeutic opportunities to target ALT cancers.

Jixuan Gao

Research Officer